additional_assessments
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
|
additional_assessments [2023/12/13 13:33] trynke |
additional_assessments [2024/10/15 10:45] (current) trynke |
||
|---|---|---|---|
| Line 9: | Line 9: | ||
| * [[DAG3]], the assessment of the **microbiome** in samples of ca. ~9.000 participants | * [[DAG3]], the assessment of the **microbiome** in samples of ca. ~9.000 participants | ||
| * [[DAG4]], the follow-up to [[DAG3]] | * [[DAG4]], the follow-up to [[DAG3]] | ||
| + | * [[DAG5]], the follow-up to [[DAG4]] | ||
| * [[EYEL]], the assessment of glaucoma in elderly participants (**EyeLife**) | * [[EYEL]], the assessment of glaucoma in elderly participants (**EyeLife**) | ||
| * [[GWAS]], the **genotyping** of ~15.000 participants | * [[GWAS]], the **genotyping** of ~15.000 participants | ||
| - | * [[UGLI]], the **genotyping** of ~38.500 (UGLI-1) plus 28,249 (UGLI-2) participants | + | * [[UGLI]], the **genotyping** of ~38.500 (UGLI-1) plus ~28,000 (UGLI-2) participants |
| * [[HAIR]], the collection & analysis of scalp **hair** samples | * [[HAIR]], the collection & analysis of scalp **hair** samples | ||
| * [[IMAL]], the assessment of CT scans of the lungs & hearts of ~12.000 participants (**ImaLife**) | * [[IMAL]], the assessment of CT scans of the lungs & hearts of ~12.000 participants (**ImaLife**) | ||
| * [[MYST]], the use of **quantified-self** devices in ~100 participants | * [[MYST]], the use of **quantified-self** devices in ~100 participants | ||
| + | * [[PGXP]], the use of a **pharmacogenetic passport** in an app by ~1000 participants | ||
| * [[NEXT]], the assessment of ~1500 **pregnant** Lifelines participants (currently an independent project) | * [[NEXT]], the assessment of ~1500 **pregnant** Lifelines participants (currently an independent project) | ||
| * [[SALT]], additional urine analyses and questionnaire on salt usage | * [[SALT]], additional urine analyses and questionnaire on salt usage | ||
| Line 34: | Line 36: | ||
| * [[INFQ]], a questionnaire on informal care (**ICAS**) | * [[INFQ]], a questionnaire on informal care (**ICAS**) | ||
| * [[MAWQ]], a questionnaire on **menopause** and **work** | * [[MAWQ]], a questionnaire on **menopause** and **work** | ||
| + | * [[MCFQ]], a questionnaire on myalgic encephalomyelitis/chronic fatigue syndrome | ||
| * [[MHDQ]], a questionnaire on the links between (familial) **mental health** and **diabetes** | * [[MHDQ]], a questionnaire on the links between (familial) **mental health** and **diabetes** | ||
| * [[MUSQ]], a questionnaire on **language** use and **musical** training | * [[MUSQ]], a questionnaire on **language** use and **musical** training | ||
| - | * [[OPTQ]], a questionnaire on **optimism** and emotion regulation | + | * [[OPBQ]], a questionnaire on **optimism**, parental bonding and emotion regulation |
| * [[RELQ]], a questionnaire on the cognitive benefits of **regional language** use | * [[RELQ]], a questionnaire on the cognitive benefits of **regional language** use | ||
| * [[ROAQ]], a questionnaire on female reproductive health (**ROAHD**) | * [[ROAQ]], a questionnaire on female reproductive health (**ROAHD**) | ||
| Line 93: | Line 96: | ||
| | **2023** | q1 | | | | | | [[3A]] | [[3B]] | | [[MHDQ]] | | | **2023** | q1 | | | | | | [[3A]] | [[3B]] | | [[MHDQ]] | | ||
| | | q2 | | | | | | [[3A]] | [[3B]] | | [[MHDQ]] | | | | q2 | | | | | | [[3A]] | [[3B]] | | [[MHDQ]] | | ||
| - | | | q3 | | | | | | [[3A]] | [[3B]] | | [[OPTQ]] | | + | | | q3 | | | | | | [[3A]] | [[3B]] | | [[OPBQ]] | |
| - | | | q4 | | | | | | [[3A]] | [[3B]] | | [[OPTQ]] + [[MCFQ]] | | + | | | q4 | | | | | | [[3A]] | [[3B]] | | [[OPBQ]] + [[MCFQ]] | |
| | **2024** | q1 | | | | | | | [[3B]] | [[4A]] | [[MCFQ]] | | | **2024** | q1 | | | | | | | [[3B]] | [[4A]] | [[MCFQ]] | | ||
additional_assessments.1702470820.txt.gz · Last modified: 2023/12/13 13:33 by trynke
Page Tools
Except where otherwise noted, content on this wiki is licensed under the following license: CC Attribution-Noncommercial-Share Alike 4.0 International
